Rao Q

No ORCID on file · 3 papers in corpus
observational 2026
Reproductive outcomes after expectant management and 5- versus 15-minute laparoscopic ethanol sclerotherapy for ovarian endometriomas: a retrospective cohort study
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1959548

BACKGROUND: Laparoscopic ethanol sclerotherapy is a fertility-preserving alternative for ovarian endometriomas, but the appropriate ethanol exposure duration remains uncertain. We compared expectant management with 5- and 15-minute ethanol …

other 2025
Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
Journal of ovarian research ·doi:10.1186/s13048-025-01729-9

Ovarian cancer ranks as the eighth most common malignancy in women globally. Early detection remains a critical challenge for improving ovarian cancer diagnosis and treatment outcomes. Our prior study demonstrated that ARHGAP40 downregulati…

observational 2024
Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/msm.943170

BACKGROUND Tumor-infiltrating immune cells (TIICs) are implicated in the survival of ovarian cancer (OVCA) patients, but their prognostic significance in advanced or metastatic OVCA patients treated with neoadjuvant chemotherapy (NCAT) has …